COSM vs MCK
Cosmos Health Inc. and McKESSON Corporation, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | COSM | MCK |
|---|---|---|
| Revenue | $65.3M | $403.4B |
| Net income | $-19.1M | $4.8B |
| Gross margin | 12.1% | 3.6% |
| Net margin | −29.3% | 1.2% |
| Return on equity | −89.1% | −179.0% |
| Diluted EPS | −$0.63 | $38.38 |
| Dividend / share | — | $3.17 |
| Payout ratio | — | 8.0% |
| Free cash flow | $-8.5M | $5.7B |
| Equity | $18.4M | $-2.2B |
| Net debt / equity | 0.17× | 0.66× |
| Current ratio | 1.00× | 0.85× |
| Revenue CAGR 5y | 3.3% | 11.1% |
| Profit CAGR 5y | — | — |
MCK bills 6180.8× the revenue of COSM, and COSM closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | COSM | MCK |
|---|---|---|
| FY2025 | $65.3M | $403.4B |
| FY2024 | $54.4M | $359.1B |
| FY2023 | $53.4M | $309.0B |
| FY2022 | $50.3M | $276.7B |
| FY2021 | $56.2M | $264.0B |
| FY2020 | $55.4M | $238.2B |
| FY2019 | $39.7M | $231.1B |
| FY2018 | $37.1M | $214.3B |
| FY2017 | $30.0M | $208.4B |
| FY2016 | $6.8M | $198.5B |
Net income by year
Bottom line
| Fiscal year | COSM | MCK |
|---|---|---|
| FY2025 | $-19.1M | $4.8B |
| FY2024 | $-16.2M | $3.3B |
| FY2023 | $-18.5M | $3.0B |
| FY2022 | $-13.8M | $3.6B |
| FY2021 | $-8.0M | $1.1B |
| FY2020 | $820,786 | $-4.5B |
| FY2019 | $-3.3M | $900.0M |
| FY2018 | $-9.1M | $34.0M |
| FY2017 | $-6.2M | $67.0M |
| FY2016 | $-601,002 | $5.1B |
Advertisement
AdSense · Rectangle 336×280